MAZEMaze Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 18343
Ticker: MAZE
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2025-01-31
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MAZE

Detail

Enriched 2026-08-14 20:47

Market cap: $1,529,268,595.04
Shares outstanding (class): 55,345,261
Shares outstanding (weighted): 55,549,168
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 141
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.mazetx.com
Description: Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Market cap and share counts drift.

Funds holding this security

79 funds · 85 positions · $105.34M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$34.69M	0.00%	1,162,190 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$19.23M	0.03%	644,329 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$7.01M	0.01%	234,961 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$6.30M	0.05%	211,159 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$5.91M	0.07%	197,936 NS	FIGI
State Street(R) SPDR(R) S&P(R) Pharmaceuticals … SPDR SERIES TRUST	XPH	$3.49M	1.13%	117,041 NS	FIGI
abrdn Healthcare Investors —	—	$3.34M	0.29%	111,766 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.99M	0.16%	66,724 NS	FIGI
abrdn World Healthcare Fund —	—	$1.79M	0.37%	59,817 NS	FIGI
iShares U.S. Pharmaceuticals ETF iShares Trust	IHE	$1.77M	0.18%	59,177 NS	FIGI
abrdn Life Sciences Investors —	—	$1.63M	0.29%	54,644 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$1.34M	0.13%	44,725 NS	FIGI
Driehaus Micro Cap Growth Fund Driehaus Mutual Funds	—	$1.30M	0.28%	43,422 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.28M	0.03%	42,984 NS	FIGI
Fidelity Small Cap Value Index Fund Fidelity Salem Street Trust	—	$911.2K	0.05%	30,527 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMAZE
FIGI_COMPOSITEBBG00NHJHS27
FIGI_SHARE_CLASSBBG00NHJHS36
CIK0001842295
ISINUS5787841007
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Maze Therapeutics is a biopharmaceutical company developing genetic medicines, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.